Dosimetric Planning Study Comparing Intensity Modulated Radiotherapy (IMRT) and 4-field Radiotherapy for Definitive Treatment of Cancer of the Cervix
NCT00981552 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2009-09-22
Summary
A theoretical planning study to compare the normal tissue irradiation when using intensity modulated radiotherapy (IMRT) as opposed to standard radiotherapy for the definitive treatment of cervical cancer.
Conditions
- Cervix Cancer
Interventions
- RADIATION
-
IMRT planning
- RADIATION
-
4-Field Radiation Planning
Sponsors & Collaborators
-
Sunnybrook Health Sciences Centre
lead OTHER
Principal Investigators
-
Gillian Thomas, MD · Sunnybrook Health Sciences Centre
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-09-30
Countries
- Canada
Study Locations
More Related Trials
-
Intensity Modulated Radiation Therapy for Head and Neck Cancer
NCT00188877 ·Status: COMPLETED ·Phase: PHASE2
-
Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell Carcinoma
NCT00934518 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
NCT03955367 ·Status: UNKNOWN ·Phase: PHASE3
-
SW-IMRT Versus ST-IMRT in the Treatment of Head and Neck Cancer
NCT04597177 ·Status: UNKNOWN ·Phase: NA
-
Single Application Brachytherapy in Cervical Cancer
NCT03110497 ·Status: UNKNOWN ·Phase: NA
-
Simultaneous Integrated Boost (SIB)- IMRT
NCT00389727 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma
NCT04976478 ·Status: NOT_YET_RECRUITING
-
Palliative Radiation for Advanced Cervical Cancer
NCT03997110 ·Status: RECRUITING ·Phase: NA
-
Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell Carcinoma
NCT01291095 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer
NCT01938105 ·Status: UNKNOWN ·Phase: PHASE2
-
Proton and Carbon Ion Radiotherapy for Cervical Cancer
NCT05141825 ·Status: COMPLETED ·Phase: NA
-
Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection
NCT02918955 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer
NCT00137358 ·Status: WITHDRAWN ·Phase: PHASE1
-
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
NCT03249519 ·Status: RECRUITING ·Phase: NA
-
Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer
NCT03175848 ·Status: UNKNOWN ·Phase: NA
-
Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck
NCT02474368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer
NCT03067610 ·Status: COMPLETED ·Phase: PHASE2
-
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
NCT01851772 ·Status: COMPLETED ·Phase: NA
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
Accelerated Modulated Fractionation (SIB-IMRT) for Head and Neck District
NCT03001570 ·Status: UNKNOWN ·Phase: PHASE2
-
Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer
NCT06039891 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer
NCT01893307 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
NCT04454489 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
NCT00713219 ·Status: COMPLETED ·Phase: PHASE2
-
HYpofractionated Pelvic Radiotherapy for Advanced Cervical Cancers INeligible for ChemoTherapy
NCT05210270 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2